Onyeka Onyeibor founded Miral Pharm in 2012 with other partners and investors. In 2018, Miral alongside its technical and financial partners acquired the assets of Evans Medical PLC (one of the four pharmaceutical manufacturing facilities in Nigeria with WHO prequalification) and subsequently changed its name to Evans Baroque Ltd.
Prior to founding Miral, he was the Deputy Managing Director of Emzor Pharmaceutical Industries. From a single company, operating only in Nigeria in 2006, Emzor became under his leadership a group of 6 companies with presence in Sierra Leone, Liberia, Ghana, and India.
Onyeka holds a Bachelors of Pharmacy degree from the University of Nigeria and a Master’s degree in drug design and development from the University of Bradford, UK.